Dudediligence.

ABIVAX Société Anonyme

ABVXNASDAQ
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

78.5M

on 2025-12-31 10-Q ↗

a raise that quarter, at its price

20M40M60M80MDec2025

Newest

No limit

F-3ASR of 2025-07-23. An automatic shelf: the form sets no dollar limit. 2 prospectus supplements filed under it since. F-3ASR ↗

1 of its filings are not read yet.

Warrants

No warrant count read from a 10-Q or 10-K.

Cash

No cash figure on file in the XBRL facts.

Raised
DateWhatSharesPriceGrossFiling
2026-06-30Public offering6,400,000$125.00$800.0M424B5 ↗
2025-07-23Public offering10,156,000$64.00$650.0M424B5 ↗